CTOs on the Move

Praestan Health

www.praestanhealth.com

 
Praestan Health is a new health technology company that is building a precision-guided suite of health and wellbeing applications to support practitioners and individuals in efficient, effective, and sustainable health behavior change.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Praestan Health raised $12M on 07/30/2018

Similar Companies

Metro Medical Supply

Metro Medical Supply is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Michigan Institute-Health Enhn

Michigan Institute-Health Enhn is a Rochester Hills, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Professional Management

Professional Management, Inc. (PMI) specializes in AR management, billing, and consulting services for physicians. We believe that the benefits of choosing PMI to manage your accounts receivable will result in selecting a billing agent that: Has

Patient Advocate Foundation Inc

Patient Advocate Foundation Inc is a Hampton, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.